Hemagen Diagnostics, Inc. is a biotechnology company. The company is headquartered in Columbia, Maryland and currently employs 15 full-time employees. The firm is primarily focused on Veterinary Clinical Diagnostics. The company is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The firm develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG, VIRGO ANA/Hep-2 IgG, VIRGO Anti-nDNA IgG, VIRGO cANCA (PR-3) Kit, VIRGO dsDNA Kit, VIRGO ENA Screen 6 Kit, VIRGO ENA Screening, VIRGO ENA Series, VIRGO pANCA myeloperoxidase (MPO) Kit and VIRGO Rheumatoid Factor Kit. The company offers various products for infectious disease, which includes VIRGO C. trach IgG, VIRGO CMV IgG and VIRGO epstein-barr virus (EBV)- viral capsid antigen (VCA) IgG. Its products are used in laboratories, hospitals and blood banks around the world.
Follow-Up Questions
Who is the CEO of Hemagen Diagnostics Inc?
William Hales is the Chairman of the Board of Hemagen Diagnostics Inc, joining the firm since 1999.
What is the price performance of HMGN stock?
The current price of HMGN is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Hemagen Diagnostics Inc?
Hemagen Diagnostics Inc belongs to Health Care industry and the sector is Health Care
What is Hemagen Diagnostics Inc market cap?
Hemagen Diagnostics Inc's current market cap is $0
